Prolonged survival of the phosphorylated form of rhodopsin during dark adaptation of Royal College Surgeons rat  by Ohguro, Hiroshi et al.
Prolonged survival of the phosphorylated form of rhodopsin during
dark adaptation of Royal College Surgeons rat
Hiroshi Ohguroa;, Ikuyo Ohguroa, Kazuhisa Mamiyaa, Tadao Maedab, Mitsuru Nakazawaa
aDepartment of Ophthalmology, Hirosaki University School of Medicine, 5 Zaifu-cho, Hirosaki, Aomori 036-8562, USA
bDepartments of Ophthalmology, University of Washington, School of Medicine, Seattle, WA 98195, USA
Received 6 May 2003; revised 30 July 2003; accepted 31 July 2003
First published online 22 August 2003
Edited by Maurice Montal
Abstract To study rhodopsin (Rho) phosphorylation and de-
phosphorylation in Royal College of Surgeons (RCS) rat retina,
speci¢c antibodies toward major Rho phosphorylation sites in
vivo, 334Ser or 338Ser, were prepared by immunization of au-
thentic phosphorylated peptides in rabbit. Enzyme-linked immu-
nosorbent assay identi¢ed that the raised antibodies exclusively
recognized either the phosphorylated 334Ser or 338Ser site. In
immuno£uorescence labeling, both antibodies recognized photo-
receptor outer segments in light-adapted retinas from Sprague^
Dawley (SD), Brown^Norway (BN) and RCS rat. During dark
adaptation, immunoreactivities toward phosphorylated 338Ser
and 334Ser sites were diminished within several hours (0.2^2 h)
in SD and BN rat retinas. However, those toward phosphory-
lated 338Ser and 334Ser sites were diminished within 4 to 7 days
in RCS rat retinas. In vitro studies demonstrated decreased
levels of both Rho phosphorylation and dephosphorylation reac-
tions in RCS retinas. However, the dephosphorylation reaction
was much more greatly a¡ected than the phosphorylation reac-
tion. Extremely prolonged survival of phosphorylated forms of
Rho may contribute to persistent misregulation of phototrans-
duction processes in retinal degeneration in RCS rat.
4 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Royal College of Surgeons (RCS) rat is the best studied
animal model for human retinitis pigmentosa (RP) [1]. In
terms of their molecular pathology of retinal degeneration,
it was revealed that mutation of the gene encoding the recep-
tor tyrosine kinase Mertk [2] causes an inability of phagocy-
tosis of the shed tips of rod outer segment (ROS) debris by
retinal pigment epithelium (RPE) [3,4]. Preservation of RCS
photoreceptors was induced by viral gene transfer of Mertk
gene [5], and mutations in the identical human homologue,
Mertk gene, have been recognized in some patients with RP
[6]. In terms of RCS photoreceptor cells, we recently found
signi¢cantly reduced expressions of K-A crystallin and rho-
dopsin kinase (RK), which are thought to be involved in
post-Golgi processing of opsin and rhodopsin (Rho) phos-
phorylation respectively, in RCS rats than those in the control
rats at the age of 3^4 weeks [7]. Therefore, we suggested that
misregulation of phototransduction pathways in rod photo-
receptors may be synergistically involved in the pathogenesis
of RCS retinal degeneration with the primary de¢cit being in
RPE phagocytosis.
In vertebrate retinal photoreceptors, it is known that phos-
phorylation and dephosphorylation of Rho is most impor-
tantly involved in the regulation of phototransduction cas-
cade [8]. In terms of phosphorylation sites in Rho, in vitro
and in vivo studies revealed that light dependent phosphor-
ylation occurs at multiple C-terminal Ser residues (334Ser,
338Ser and 343Ser) [9^12]. We previously demonstrated that
monophosphorylated Rho at 334Ser and 338Ser were pre-
dominantly found in mice retinas upon £ash and continuous
illumination, and these sites had di¡erent kinetics of dephos-
phorylation and spatial distribution within ROS [10]. There-
fore, taken together, it is of great interest to study in vivo Rho
phosphorylation and dephosphorylation in RCS retinal de-
generation.
Here, to gain additional insight into photoreceptor func-
tions during RCS retinal degeneration, we prepared speci¢c
antibodies toward major Rho phosphorylation sites, 334Ser
and 338Ser, and studied in vivo Rho phosphorylation and
dephosphorylation in RCS and control, Sprague^Dawley
(SD) or Brown^Norway (BN), rat retinas utilizing these anti-
bodies in conjunction with in vitro biochemical assays of Rho
phosphorylation and dephosphorylation.
2. Materials and methods
Unless otherwise stated, all procedures were performed at 4‡C or on
ice using ice-cold solutions. RCS, SD or BN rats (Crea, Tokyo, Ja-
pan) reared in cyclic light conditions (700 lux, 12 h on/12 h o¡) were
used. Authentic phosphorylated peptides, P-Rho334-peptide
(DDEApSATASK), P-Rho338-peptide (CEASATApSKT), and non-
phosphorylated peptides, Rho334-peptide (DDEASATASK) and
Rho338-peptide (CEASATASKT) were puri¢ed by HPLC column
(purities s 98%). Rat ROS and urea-washed ROS membranes were
prepared using 200 freshly dissected retinas from dark-adapted BN
rats as described previously [12]. Rho concentrations were determined
in detergent solutions from the di¡erence in absorbance at 500 nm
before and after bleaching in the presence of NH2OH by assuming
O500 to be 41 000 and the molecular weight to be 38 000.
2.1. Preparation of speci¢c antibodies toward phosphorylated Rho at
334Ser or 338Ser
Speci¢c antisera toward phosphorylated Rho at 334Ser or 338Ser
were obtained by immunization of phosphorylated authentic peptides
P-Rho334 peptide or P-Rho338 peptide chemically conjugated with
bovine thyroglobulin and complete adjuvant to rabbit. Antisera were
each further puri¢ed into IgG [7], and 0.1 mg of them were each
incubated with urea-washed ROS (20 mg of Rho) at room temper-
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ature for 2 h. Then the mixture was ultracentrifuged at 100 000Ug for
1 h. The resultant supernatant was used as speci¢c antibody toward
phosphorylated Rho at 334Ser or 338Ser.
2.2. Preparation of phosphorylated photolyzed Rho (P-Rho*)
After overnight dark adaptation, fresh ROS (5 mg of Rho) ob-
tained from 6- to 8-week-old BN rats [12] was dissolved in 0.5 ml
of bu¡er A (100 mM Na-phosphate bu¡er, pH 7.2, 5 mM MgCl2,
100 mM KCl) containing 0.5 mM [Q-32P]ATP (300 cpm/nmol) or cold
ATP and incubated at 30 ‡C for 10 min under a 150-W lamp from a
distance of 20 cm. The reaction was terminated by the addition of
bu¡er B (200 mM Na-phosphate bu¡er, pH 7.2 containing 5 mM
adenosine, 100 mM KF and 200 mM EDTA). P-Rho* pellet was
obtained by centrifugation. For Rho phosphorylation kinetics, radio-
active fresh P-Rho* pellets from four dark-adapted retinas (3-week-
old SD, BN or RCS) were subjected to sodium dodecyl sulfate^poly-
acrylamide gel electrophoresis (SDS^PAGE). Rho band was cut out
and its radioactivity was counted.
2.3. Immuno£uorescence microscopy
Under deep ether anesthesia, rats kept under di¡erent illumination
conditions were perfused with 300 ml of 4% paraformaldehyde in
phosphate-bu¡ered saline (PBS), and retinas were dissected out and
embedded in para⁄n. After the depara⁄nization, retinal sections ver-
tically through the optic disc at 4 Wm thickness were blocked with 3%
bovine serum albumin (BSA) in PBS for 1 h and then incubated
successively with anti-P-Rho antibodies (1:500) and FITC-conjugated
anti-rabbit IgG (Cappel, Durham, NC, USA) for 1 h each at room
temperature.
2.4. Dephosphorylation of P-Rho*
Quantifying levels of dephosphorylation of P-Rho* was performed
as described previously. [14] Brie£y, radioactive rat P-Rho* pellet
(5 mg of Rho) was extensively washed with hypotonic and isotonic
bu¡ers and incubated with fresh ROS (1 mg of Rho) from RCS rat
(3 or 4 weeks old) or SD rat (3 weeks old) at 30‡C under dark for 1 to
6 h. After the incubation radioactive counting was performed in scin-
tillation cocktail after solubilization by perchloric acid.
2.5. Enzyme-linked immunosorbent assay (ELISA)
Authentic peptides (50 Wg/ml) in PBS were coated onto 96-well
microtiter plate (Dynatech CO.) overnight at 4‡C. After blocking
with 1% BSA for 1 h at room temperature, the wells were incubated
successively with anti-peptides antibodies at graded dilutions (0^
25 000 times) and HRP-labeled anti-rabbit IgG (1:3000 dilutions,
Cappel, Durham, NC, USA) for 1 h at 37‡C. The wells were exten-
sively washed with 0.035% Tween 20 in PBS and antigen-antibody
binding was visualized with o-phenylenediamine as a substrate. The
OD was measured at 492 nm.
3. Results
As shown in Fig. 1A,B, anti-P-Rho334 or anti-P-Rho338
IgG exclusively recognized P-Rho334 or P-Rho338 peptide,
respectively, with no immunoreactivities toward other pep-
tides. In Western blot analysis (Fig. 1C), these anti-P-Rho
IgGs speci¢cally reacted with P-Rho, but had no immunore-
activity toward the truncated form of Rho obtained by endo-
proteinase Asp-N, which was missing the C-terminal 19 amino
acids, 330DDEASATASKTETSQVAPA, containing all possi-
ble phosphorylation sites [13].
Using these speci¢c antibodies, immunohistochemical study
was performed. Immunoreactivities by these antibodies were
speci¢cally recognized retinal outer segments of light-adapted
BN (lanes 2^4) and RCS rats (lanes 5^7), and those were
diminished within 1 h and 7 days, respectively (Fig. 2). These
changes in immuno£uorescence labeling indicated light-depen-
dent phosphorylation of Rho at 334Ser and 338Ser sites and
their dephosphorylation after following dark adaptation. Dur-
ing the dephosphorylation of both sites, tips of ROS were
slower than bases as similarly observed in our previous study
using mice [10]. Using this method, kinetics of dephosphory-
lation of phosphorylated 334Ser and 338Ser sites of normal
(BN and SD) and RCS rats were studied by comparing their
changes in vertical lengths of immuno£uorescence-labeled
ROS during the dark adaptation (Fig. 3). In BN rat, dephos-
phorylation of 334Ser and 338 Ser sites went to completion
within 1 or 0.2 h, respectively, and in SD rat, immunostaining
by P-Rho338 was diminished until 1^3 h dark adaptation,
while that toward P-Rho334 remained until 2^4 h dark adap-
tation. In RCS rat, however, dephosphorylation of both sites
was much slower than in the normal control rat (SD and BN)
retina. That is, immunostainings by P-Rho338 and P-Rho334
were diminished until dark adaptation for 4 and 7 days, re-
spectively.
Fig. 1. Characterization of anti-P-Rho334 and anti-P-Rho338 IgG.
A⁄nity puri¢ed anti-P-Rho334 or anti-P-Rho338 IgG were sub-
jected to ELISA (A,B) using authentic peptides and Western blot
analysis using endoproteinase Asp-N treated (enzyme:substrate=
1:1000 for overnight at room temperature) [13] or non-treated
P-Rho* (C). In Western blotting, primary and secondary antibodies
were probed at 1:2000 dilutions and speci¢c antibody/antigen bind-
ing was visualized by ECL (Amersham)[7]. ELISA was performed
in triplicate. Data are expressed as the meansRS.D.
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The in vitro biochemical assay of Rho phosphorylation
revealed that levels of Rho phosphorylation in 3-week-old
RCS rat were slightly lower than those in 3-week-old SD
rat, and those of RCS rat decreased to approximately 20%
of the initial levels in 3^5 weeks (Fig. 4, upper panel). In terms
of dephosphorylation of P-Rho, approximately 40% of P-Rho
was dephosphorylated by SD ROS (3 weeks old) during 6 h
incubation, while almost no dephosphorylation was observed
by incubation with ROS from 3- or 4-week-old RCS rat
(Fig. 4, lower panel).
4. Discussion
In the present study, we studied Rho phosphorylation and
dephosphorylation in normal (SD, BN) and retinal degener-
ation rats (RCS) using speci¢c antibodies toward major phos-
phorylation sites of Rho in vivo, 334Ser and 338Ser, and
found following observation; 1) Dephosphorylation of
338Ser and 334Ser went to completion within 0.2 and 1 h of
dark adaptation in BN rat retina. This result is closely com-
parable with previous results obtained by biochemical assays
using mice [10,11]. 2) Dephosphorylation of both sites in al-
bino species (SD rat) took slightly longer time periods (2^4 h).
3) However, dephosphorylation of these sites in RCS rat ret-
ina took place during several days of dark adaptation. In
addition, biochemical assays demonstrated that in RCS retina,
phosphatase activities were much lower than kinase activities
in terms of Rho phosphorylation as compared with SD retina.
Therefore, our data indicated that misregulation of the visual
transduction cascade in photoreceptor by marked survival of
phosphorylated forms of Rho may facilitate RCS retinal de-
generation caused primarily by Mertk mutation. Similar to
this mechanism, we have found that, in retinal degeneration
model of cancer-associated retinopathy, anti-recoverin anti-
body was internalized into photoreceptor cells [15,16], and
blocked recoverin function, Ca2þ-dependent regulation of
RK, resulting in enhancement of Rho phosphorylation. In
addition, Rho mutants within the C-terminus, in which
345Val and 347Pro are the most common sites of mutations
causing autosomal dominant retinitis pigmentosa [17,18], were
phosphorylated at signi¢cantly higher levels compared with
wild type [19].
Fig. 2. Immuno£uorescence labeling of anti-P-Rho334 and anti-P-Rho338 IgG in light- or dark-adapted rat retinas. Retinas obtained from
3-week-old BN and RCS rats kept under several illumination conditions were subjected to imuno£uorescence labeling by anti-P-Rho antibodies.
GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer; OS,
outer segment. Scale bar= 50 Wm.
FEBS 27596 27-8-03 Cyaan Magenta Geel Zwart
H. Ohguro et al./FEBS Letters 551 (2003) 128^132130
It was suggested that down-regulated or absence of Rho
phosphorylation can cause retinal degeneration, based upon
several studies using site-directed mutagenesis of Rho or
transgenic mice carrying Rho with deleted phosphorylation
sites. However, it was demonstrated that the C-terminus of
Rho possesses several biochemical properties including gene
product synthesis, transport and immunogenic properties, in
addition to phosphorylation sites [20^22]. Therefore, retinal
degeneration in these Rho mutants may be caused by mech-
anisms other than down-regulation of Rho phosphorylation.
It was reported that RK mutations (deletion of the C-termi-
nus) cause Oguchi disease, an autosomal recessive form of the
congenital stationary night blindness [23^25], and a functional
assay identi¢ed that such a RK mutant is an inactive form
[26]. Oguchi disease is not a retinal degenerative disease but is
clinically characterized by normal light adaptation and very
slow dark adaptation [25]. In addition, RK knock-out mice
displayed signi¢cantly slow recovery from light stimuli,
although the retinal morphology was normal [27]. Therefore,
taken together with the above observations, we speculated
that down-regulated Rho phosphorylation causes dysfunction
of phototransduction in photoreceptors but not retinal degen-
eration, while misregulation of the phototransduction path-
way by abnormally high levels of Rho phosphorylation may
constitute a common mechanism causing photoreceptor cell
death.
In conclusion, signi¢cantly prolonged survival of phosphor-
ylated form of Rho found in RCS rat retina leads to mis-
regulation of the visual transduction cascade and this may
be an important mechanism responsible for retinal degenera-
tion in RCS rat.
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Fig. 3. Kinetics of dephosphorylation in phosphorylated 334Ser and
338Ser sites in BN, SD and RCS rats. Three-week-old BN, SD and
RCS rats (n=15 rats each) kept under illumination condition (700
lx) for 1 h were incubated under dark condition. At di¡erent time
points (BN rats: 0, 0.1, 0.2, 0.5 and 1 h; SD rats: 0, 1, 2, 3 and
4 h; RCS rats: 0, 1, 2, 4 and 7 days), three rats (six eyeballs) in
each category were subjected to imuno£uorescence labeling by anti-
P-Rho antibodies. Photographs of the sections were taken. Vertical
length of photoreceptor outer segment layers and that of £uores-
cence labeling were measured at temporal points 1.0 mm apart from
optic disc from six di¡erent points from six di¡erent eyeballs and
their ratios were plotted. Data are expressed as the meansRS.D.
Fig. 4. Rhodopsin phosphorylation and dephosphorylation in vitro.
Upper panel: Rho phosphorylation was performed using [Q-32P]ATP
and ROS of RCS rats (3^5 weeks old) and SD rats (3 weeks old) as
described in Section 2. After the reaction, the radioactive Rho
bands in SDS^PAGE was counted and plotted. Lower panel: De-
phosphorylation of Rho of 3-week-old SD and 3- to 4-week-old
RCS rat ROS was studied over 6 h by incubation with radioactive
P-Rho* pellet as described in Section 2. Experiments were per-
formed in triplicate using fresh preparations. Data are expressed as
the meansRS.D.
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